Amgen Clinical Trials

Clinical trials sponsored by Amgen — phases, conditions and reported results. Data from ClinicalTrials.gov.

• A Study to Assess the Safety, Tolerability, and Efficacy of Rocatinlimab in Adolescent Participants With Moder
  Phase 3 · Atopic Dermatitis · Completed · Jul 24, 2026
• A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE)
  Phase 3 · Atopic Dermatitis · Completed · Jul 23, 2026
• A Study Assessing Rocatinlimab on Vaccine Antibody Response in Moderate-to-severe Atopic Dermatitis (AD) (ROCK
  Phase 3 · Atopic Dermatitis · Completed · Jul 23, 2026
• Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBr
  Phase 3 · KRAS p, G12c Mutated /Advanced Metastatic NSCLC · Completed · May 10, 2023
• Sotorasib and Panitumumab Versus Investigator's Choice for Participants With Kirsten Rat Sarcoma (KRAS) p.G12C
  Phase 3 · Colorectal Cancer · Completed · Jul 22, 2026
• A Study of Talimogene Laherparepvec (T-VEC) in Combination With Pembrolizumab in Patients With Metastatic and/
  Phase 2 · Sarcoma · Active, not recruiting · Oct 29, 2025
• A Study of Sotorasib (AMG 510) in Participants With Stage IV NSCLC Whose Tumors Harbor a KRAS p.G12C Mutation
  Phase 2 · Non-small Cell Lung Cancer · Terminated · Jul 13, 2026
• Study Evaluating Tarlatamab in Chinese Participants With Advanced Small Cell Lung Cancer After Two or More Pri
  Phase 2 · Extensive Stage Small Cell Lung Cancer · Active, not recruiting · Apr 15, 2026
• Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor
  Phase 1 · Advanced Solid Tumor · Completed · Mar 12, 2026
• A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared W
  Phase 4 · Gout · Completed · Jul 1, 2026
• Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HIgh-Risk (HR) First Relapse
  Phase 3 · Leukemia, Acute Lymphoblastic · Completed · Jul 13, 2020
• A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Hori
  Phase 3 · Atopic Dermatitis · Completed · Jun 26, 2026
• Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke
  Phase 3 · Coronary Heart Disease · Completed · Jun 25, 2026
• Tezepelumab Efficacy and Safety in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Depende
  Phase 3 · Asthma · Terminated · Jun 18, 2026
• Denosumab for Smoldering Multiple Myeloma
  Phase 2 · Smoldering Multiple Myeloma · Completed · Feb 15, 2023

Trials by company

PfizerMerck (MSD)RocheNovartisAstraZenecaJohnson & Johnson (Janssen)Bristol Myers SquibbSanofiGSKEli LillyAbbVieAmgenBayerBoehringer IngelheimNovo NordiskTakedaGilead SciencesModernaBioNTechRegeneronVertexBiogenDaiichi SankyoAstellas PharmaEisaiOtsukaServierIncyteCelltrionSamsung BioepisHanmi PharmaceuticalYuhan

All trials